Research ArticleCancer

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

See allHide authors and affiliations

Science Translational Medicine  19 Jul 2017:
Vol. 9, Issue 399, eaaa0984
DOI: 10.1126/scitranslmed.aaa0984

Article Information

vol. 9 no. 399

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication December 21, 2016
  • Accepted for publication May 9, 2017
  • .

Author Information

  1. Donald M. O’Rourke1,
  2. MacLean P. Nasrallah2,*,
  3. Arati Desai3,*,
  4. Jan J. Melenhorst4,*,
  5. Keith Mansfield5,*,
  6. Jennifer J. D. Morrissette6,
  7. Maria Martinez-Lage2,,
  8. Steven Brem1,
  9. Eileen Maloney1,
  10. Angela Shen7,
  11. Randi Isaacs5,
  12. Suyash Mohan8,
  13. Gabriela Plesa4,
  14. Simon F. Lacey4,
  15. Jean-Marc Navenot4,
  16. Zhaohui Zheng4,
  17. Bruce L. Levine4,
  18. Hideho Okada9,
  19. Carl H. June4,
  20. Jennifer L. Brogdon5 and
  21. Marcela V. Maus10,
  1. 1Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  2. 2Division of Neuropathology, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  3. 3Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  4. 4Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA 19104, USA.
  5. 5Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.
  6. 6Division of Precision and Computational Diagnostics, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  7. 7Novartis Oncology, East Hanover, NJ 07936, USA.
  8. 8Division of Neuroradiology, Department of Radiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA.
  9. 9Department of Neurosurgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  10. 10Cellular Immunotherapy Program, Cancer Center and Department of Medicine, Massachusetts General Hospital, Boston, MA 02129, USA.
  1. Corresponding author. Email: mvmaus{at}mgh.harvard.edu
    • * These authors contributed equally to this work.

    • Present address: Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.

    Altmetric

    Article usage

    Article usage: July 2017 to June 2021

    AbstractFullPdf
    Jul 20171221921034104
    Aug 20172408299557
    Sep 20171681211406
    Oct 20171235141318
    Nov 201791795223
    Dec 201775461148
    Jan 201883993167
    Feb 201857380105
    Mar 201862164125
    Apr 201856163113
    May 201854156108
    Jun 201820954078
    Jul 2018324109161
    Aug 20180425260
    Sep 20180379289
    Oct 20180475323
    Nov 20180371226
    Dec 20180347190
    Jan 20193451243
    Feb 201913565281
    Mar 20198611291
    Apr 20197552238
    May 201912529208
    Jun 20195485202
    Jul 201911553267
    Aug 201913601268
    Sep 20196551238
    Oct 201915583266
    Nov 201920406188
    Dec 201910362177
    Jan 202018419244
    Feb 202015313197
    Mar 202021487259
    Apr 202018347273
    May 202013270298
    Jun 202010245194
    Jul 202013247199
    Aug 202010175165
    Sep 202021199173
    Oct 202013264193
    Nov 202010248229
    Dec 202011353250
    Jan 202110315226
    Feb 202114305261
    Mar 202110338304
    Apr 20217323267
    May 202116413246
    Jun 20215167127

    Stay Connected to Science Translational Medicine

    Navigate This Article